Status:
COMPLETED
Nutritional Intake and Bone Health in Celiac Disease
Lead Sponsor:
George Mason University
Conditions:
Celiac Disease
Eligibility:
All Genders
18+ years
Brief Summary
Celiac disease leads to malnutrition and secondary conditions including osteoporosis. The dietary habits of adults with untreated, undiagnosed celiac disease has not yet been observed, but presents a ...
Detailed Description
Celiac disease leads to malnutrition and secondary conditions including osteoporosis. The dietary habits of adults with untreated, undiagnosed celiac disease has not yet been observed, but presents a ...
Eligibility Criteria
Inclusion
- Adults aged 18+ years with a complete 24-hour recall in WWEIA and a completed celiac disease serologic test. Two groups were used in the analysis. The control group consisted of a normal adult population without celiac disease, as indicated by a negative serologic test for celiac disease and no self-reported celiac disease. The serologically positive group were considered to have undiagnosed, untreated celiac disease based on a positive serologic test for celiac disease (EMA+), no self-reported celiac disease, and no adherence to a gluten-free diet. NHANES employs two steps of serologic tests for selected participants to screen for celiac disease antibodies that develop as a T-cell-mediated response to gluten.
Exclusion
- Adults were excluded if they were pregnant or breastfeeding at the time of the study, or if they reported any history of celiac disease.
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2017
Estimated Enrollment :
13893 Patients enrolled
Trial Details
Trial ID
NCT03364556
Start Date
June 1 2016
End Date
November 1 2017
Last Update
December 6 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.